Is It Smart To Stock Up On Gun Stocks?

Sometimes, journalists’ explanations of movements in asset prices are easily mocked: “stocks rise as investors become more confident about Europe” one day, followed the next by “stocks fall as investors become more concerned about Europe.” But we’re pretty confident that the rise in prices at gun companies Smith & Wesson Holding Corporation (NASDAQ:SWHC) and Sturm, Ruger & Company (NYSE:RGR) on November 7th against a falling market was primarily driven by President Obama’s re-election. Smith & Wesson closed on November 6th up 286% from when he took office on January 20th, 2009 (almost four years ago, obviously) and Ruger was up over 600%. Concern that the federal government will further regulate sales of guns- and, in some quarters, fear that it will actually try to prevent even responsible owners from buying them for hunting or self-defense- has driven up demand, and the market seems to be theorizing that this trend will continue. Smith & Wesson was up about 8%, and Sturm, Ruger about 5%.

The first quarter of Smith & Wesson’s fiscal year ended in June, with sales rising 59% versus the same quarter a year earlier. Operating expenses actually fell- apparently the company didn’t need to spend as much on sales and marketing- and Smith & Wesson Holding Corporation posted $17.8 million in earnings, up from about $800 million a year earlier. Working capital ballooned, but the company was able to convert over half of its earnings into operating cash flow. Sturm, Ruger & Company, which has a standard fiscal year, reported a 47% increase in revenue during the third quarter compared to the same period in 2011; its margins were up as well, and so the growth rate of earnings at that company was slightly higher. This gunmaker didn’t increase its working capital as much, so surplus cash was used to buy marketable securities.

RENAISSANCE TECHNOLOGIES

Smith & Wesson Holding Corporation trades at 21 times trailing earnings (and only 12 times consensus estimates for the fiscal year ending in April 2014) while Sturm, Ruger & Company carries a trailing P/E of 15. We would expect that at some point these companies’ growth would have to slow, and possibly even go negative, as the run on gun sales dies down. So perhaps some caution is warranted for investors looking to get in now. About a month and a half ago we had noted an insider purchase at Smith & Wesson; the same insider had also been buying shares in March (read about the insider purchase).

Our database of hedge funds shows that the largest investor in gun stocks at the end of June- according to 13F filings- was Renaissance Technologies, whose founder Jim Simons is a multi-billionaire thanks to the fund’s good returns. At the end of the second quarter Renaissance owned 2.2 million shares of Smith & Wesson and 1 million shares of Sturm, Ruger (find more stocks that Renaissance owned). David Gallo’s Valinor Management initiated a position of about 280,000 shares in Sturm, Ruger between April and June (see more stock picks from Valinor Management).

We would compare the gunmakers to TASER International, Inc. (NASDAQ:TASR) and to sporting goods stores Cabelas Inc (NYSE:CAB) and Dicks Sporting Goods Inc (NYSE:DKS). Taser trades at a high premium to the gun manufacturers: its trailing and forward P/Es are 90 and 36, respectively. It revenues have been up, and this drove a large increase in net income last quarter compared to a year ago, but that pricing is too high for us. The sporting goods stores- which sell guns and other hunting equipment, but certainly aren’t overly exposed to gun demand- trade at forward earnings multiples in the teens. Cabela’s, which has more of a concentration on hunting and fishing activities, saw its earnings come in 29% higher last quarter than in Q3 2011; Dick’s experienced a decline in earnings.

We don’t think that sporting goods stores look good against other retailers, and the gun manufacturers seem better priced if an investor has confidence that the high gun sales theme will continue. As we’ve noted, however, we think that the market has to hit saturation at some point and think that potential buyers should check their growth assumptions closely.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!